Clinical and epidemiological data on catheter-associated bloodstream infections among patients undergoing hemodialysis treatment

Mirazimova I.S., Karunnaya A.V., Yesayan A.M.

First Pavlov State Medical University of St. Petersburg, Saint Petersburg, Russia

This literature review analyzes data on the prevalence of catheter-associated bloodstream infection (CABI) in patients receiving renal replacement therapy by hemodialysis. Key epidemiological indicators, including the incidence of CABI, the spectrum of main pathogens and risk factors are considered in detail. Current data on complex preventive measures, including the use of antimicrobial solutions for closing the catheter, antiseptic barrier caps, are presented. The effectiveness of transparent adhesive dressings with chlorhexidine gluconate, local antiseptic and antibacterial ointments is discussed. The importance of early detection of infection and timely administration of empirical antimicrobial therapy is emphasized.

Keywords

About the Authors

Irina S. Mirazimova – Nephrologist, Chronic Hemodialysis Department, First Pavlov State Medical University of St. Petersburg. Address: 6–8 Lev Tolstoy str., Saint Petersburg, 197022; tel.: +7 (981) 196-48-61; e-mail: irinamirazimova@mail.ru. ORCID: 0009-0001-0719-7569.
Anna V. Karunnaya – Nephrologist, Head of the Chronic Hemodialysis Department, Teaching Assistant, Nephrology and Dialysis Department, First Pavlov State Medical University of St. Petersburg. Address: 6–8 Lev Tolstoy str., Saint Petersburg, 197022; Tel.: +7 (931) 269-20-90; E-mail: a.v.karunnaya@yandex.ru. ORCID: 0000-0003-0758-8137.
Ashot M. Yesayan – Dr.Sci. (Med.), Professor, Head of the Department of Nephrology and Dialysis, First Pavlov State Medical University of St. Petersburg, Chief Nephrologist of the North-Western Federal District of the Russian Federation. Address: 6–8 Lev Tolstoy str., Saint Petersburg, 197022; Tel.: +7 (921) 931-22-53; E-mail: essaian.ashot@
gmail.com. ORCID: 0000-0002-7202-3151.

Similar Articles